Results 171 to 180 of about 11,033 (240)

Population PK/PD Modeling for Evaluation of Intertwining Effects of Drug and Disease on Thrombocytopenia in Acute Leukemias. [PDF]

CPT Pharmacometrics Syst Pharmacol
Sou T, Malek K, Weber HJ.
europepmc   +1 more source

Comprehensive Pathophysiology Repository for PBPK Modeling in Liver Cirrhosis: Quantifying Continuous Disease Progression and Population Variability. [PDF]

CPT Pharmacometrics Syst Pharmacol
Schneider ARP, Baier V, Schlender JF, Kuepfer L.   +3 more
europepmc   +1 more source

Follow-Up Bias in Tumor Dynamic Modeling: A Comparison of Classical and Neural-ODE Approaches. [PDF]

CPT Pharmacometrics Syst Pharmacol
Turner DC, Laurie M, Li S, Ngo HX, Li C, Jin JY, Lu J, Brooks L.   +7 more
europepmc   +1 more source

Integrating B Cell Differentiation Model With Real-World Data Informs Determinants for Antibody-Secreting Cell Depletions in Systemic Sclerosis. [PDF]

CPT Pharmacometrics Syst Pharmacol
Nakada T, Saito R, Ishigaki S, Takei H, Yoshimoto K, Akiyama M, Takeuchi T, Kaneko Y, Miyoshi F.   +8 more
europepmc   +1 more source

A QSP Model of Valproic Acid Toxicity in Pediatric and Adult Populations: Implications for Formulation Selection and L-Carnitine Supplementation. [PDF]

CPT Pharmacometrics Syst Pharmacol
Schiavo A, Maldonado C, Vázquez M, Fagiolino P, Trocóniz IF, Ibarra M.   +5 more
europepmc   +1 more source

Physiologically-Based Pharmacokinetic Model-Informed Labeling for Cariprazine Drug Interactions With CYP3A Inhibitors. [PDF]

CPT Pharmacometrics Syst Pharmacol
Riad MMH, Marroum P, Shebley M, Xiong H.
europepmc   +1 more source

Neural Controlled Differential Equation and Its Application in Pharmacokinetics and Pharmacodynamics. [PDF]

CPT Pharmacometrics Syst Pharmacol
Wu Z, Luo P, Chen R, Liu Y, Jian W, Zhou T.   +5 more
europepmc   +1 more source

Redefining Parameter Estimation and Covariate Selection via Variational Autoencoders: One Run Is All You Need. [PDF]

CPT Pharmacometrics Syst Pharmacol
Rohleff J, Bachmann F, Nahum U, Bräm D, Steffens B, Pfister M, Koch G, Schropp J.   +7 more
europepmc   +1 more source

Model-Based Meta-Analysis of Overall Survival in Vulnerable Platinum-Ineligible NSCLC Populations. [PDF]

CPT Pharmacometrics Syst Pharmacol
Chen J, Wada R, Zhang N, Graupner V, Morris S, Hu Y, Zhang W, Kassir N, Wu B, Chan P.   +9 more
europepmc   +1 more source